- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/655 - Somatostatins
Patent holdings for IPC class C07K 14/655
Total number of patents in this class: 146
10-year publication summary
|
9
|
8
|
12
|
7
|
3
|
10
|
1
|
2
|
12
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glytech, Inc. | 63 |
7 |
| BCN Peptides, S.A. | 31 |
6 |
| Braasch Biotech LLC | 8 |
5 |
| Immunwork Inc. | 26 |
5 |
| The Salk Institute for Biological Studies | 447 |
5 |
| Tel Hashomer Medical Research Infrastructure and Services Ltd. | 326 |
5 |
| Ipsen Pharma S.A.S. | 376 |
4 |
| University Hospital Basel | 15 |
4 |
| Adepthera LLC | 11 |
4 |
| UCL Business Ltd | 679 |
4 |
| The Administrators of the Tulane Educational Fund | 411 |
3 |
| Camurus AB | 145 |
3 |
| Ipsen Manufacturing Ireland Limited | 7 |
3 |
| Italfarmaco SpA | 158 |
3 |
| Recordati AG | 36 |
3 |
| RayzeBio, Inc. | 91 |
3 |
| Novartis AG | 10174 |
2 |
| The Regents of the University of California | 20868 |
2 |
| AmideBio, LLC | 17 |
2 |
| British Columbia Cancer Agency Branch | 178 |
2 |
| Other owners | 71 |